Danforth Advisors Expands Practice With Appointment of Jeff Rona as Director of West Region

Print
| Source: Danforth Advisors, LLC

CAMBRIDGE, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Danforth Advisors, specialists in accounting, finance support and strategy for life science companies, today announced its latest expansion effort with the appointment of Jeff Rona as Director, West Region. With more than 25 years of experience, Mr. Rona will oversee service to clients in the Rocky Mountain states, Texas and the West Coast – where demand for experienced life science finance professionals is on the rise.

In Colorado alone, where Mr. Rona is based, funding for life science companies reached a record $1.2 billion in 2017 – an increase of 100% from the previous year, according to the Colorado BioScience Association. The local cluster comprises more than 720 companies and is supported by four top-ranked university bioscience programs, 30 federal research laboratories and a growing number of incubators. Under Mr. Rona’s direction, Danforth will assist both emerging and established life science companies as an outsourced finance team, in part or whole, to free internal resources for focus on research & development and other core activities.

“Danforth uniquely understands the finance needs and operations of life science companies, who can tap into our expertise on a flexible basis without the excessive time and cost of securing in-house talent,” said Gregg Beloff, Founding Managing Director of Danforth. “We’re excited to welcome Jeff and extend this expertise to the western U.S.”

“Danforth has become the top resource of its kind for the life science industry, and I’m excited to join such a highly regarded organization and bring additional focus and local resources to the western region,” said Mr. Rona. “There is tremendous opportunity to provide our expertise and hands-on experience to both the new and established life science hubs seeking support.”

Mr. Rona is a veteran of the life science sector as a former investment banker and strategic financial executive, with experience leading operations and transactions for both private and public companies. He previously held senior leadership positions for GlobeImmune, AlgoRx Pharmaceuticals and Antigenics (now Agenus), and later formed a successful life sciences financial advisory practice. He has raised more than $500 million for life science start-ups and led multiple liquidity events. He began his career at Coopers & Lybrand and UBS Investment Bank and holds a BS in Accounting from Case Western Reserve University.

About Danforth Advisors
Danforth specializes in accounting, finance support and strategy for life science companies. Our services range from execution of day-to-day finance and accounting functions to strategic CFO advisory, capital raising, financial and operational planning and analysis, and transactional support and execution for public offerings, mergers and acquisitions. Clients at all phases of the corporate life cycle can take advantage of these services on a part-time, interim or project basis, scaling as needed. Danforth was founded in 2011 and has served over 260 life science and digital health companies with our unique, modular approach. Additional information is available at www.danforthadvisors.com.